06855 亞盛醫藥－Ｂ
按盘价 
44.850 +0.600 (+1.356%) 盈利能力分析
| 2024/12 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| 资产回报率 (%) | -15.843% | -34.729% | -30.602% | -33.501% | -46.157% |
| 股东资金回报率 (%) | -249.796% | -394.665% | -107.451% | -75.184% | -78.016% |
| 资本运用回报率 (%) | -27.938% | -59.100% | -45.299% | -30.339% | -46.574% |
边际利润分析
| 2024/12 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| 毛利率 (%) | 97.034% | 86.241% | 89.510% | 88.076% | 84.209% |
| 未计利息、税项、折旧及摊销前利润率 (%) | -28.062% | -350.068% | -372.380% | -2845.926% | -5196.699% |
| 税前边际利润率 (%) | -40.305% | -420.238% | -423.045% | -2981.903% | -5425.285% |
| 纯利率 (%) | -41.343% | -416.984% | -421.019% | -2803.382% | -5442.618% |
变现能力分析
| 2024/12 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| 流动比率 (X) | 1.264 X | 1.439 X | 1.857 X | 5.221 X | 3.907 X |
| 速动比率 (X) | 1.258 X | 1.422 X | 1.846 X | 5.210 X | 3.907 X |
财务杠杆分析
| 2024/12 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| 总负债 / 总资产比率 (%) | 89.527% | 97.175% | 85.561% | 58.003% | 51.092% |
| 总债项 / 总资产比率 (%) | 63.736% | 71.813% | 63.341% | 36.880% | 30.600% |
| 净债项 / 总资产比率 (%) | 15.558% | 28.066% | 10.617% | -22.433% | -28.579% |
| 总债项 / 股东资金比率 (%) | 631.542% | 2972.003% | 438.686% | 87.815% | 62.566% |
| 长期债项 / 股东资金比率 (%) | 336.660% | 1951.754% | 311.836% | 83.810% | 56.594% |
| 净债项 / 股东资金比率 (%) | 154.162% | 1161.531% | 73.530% | -53.415% | -58.433% |
| 净现金 / (债项) ($) | (4.07亿) | (7.02亿) | (3.00亿) | 6.60亿 | 4.95亿 |
| 每股净现金 / (债项) ($) | (1.292) | (2.418) | (1.133) | 2.509 | 2.189 |
| 总债项 / 资本运用比率 (%) | 114.974% | 114.645% | 91.977% | 42.044% | 36.408% |
| 利息盈利率 (X) | N/A | N/A | N/A | N/A | N/A |
营运效率分析
| 2024/12 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| 存货周转率日数 (日) | 142.838日 | 153.054日 | 110.987日 | 431.025日 | N/A |
| 应收贸易帐周转率日数 (日) | 42.624日 | 164.631日 | 94.268日 | 705.780日 | N/A |
| 应付贸易帐周转率日数 (日) | 30.597日 | 138.121日 | 144.826日 | 616.106日 | 534.234日 |
| 备注： | 实时报价更新时间为16/05/2025 17:59 |
| 港股实时基本市场行情由香港交易所提供; 香港交易所指定免费发放实时基本市场行情的网站。 | |
| 股东应占溢利/(亏损) () | RMB -405,433,000 |
| 增长率 | -56.200% |
| 每股盈利/(亏损) | RMB -1.340 |
| 每股账面资产净值 (¥) | RMB 0.838 |